RDT in Antibiotic Research

The industrial antibiotic yield has been enhanced by technological innovations and the development of strain improvement of microorganisms through random mutation and screening. The recombinant DNA technology and its application in antibiotic production by microorganisms have given yield enhancement and design of biosynthetic pathways for new antibiotic production. Genetic manipulation of biosynthetic pathways is very useful process for producing antagonistic products of complex bioactive metabolites.

 

 

    Related Conference of RDT in Antibiotic Research

    October 25-26, 2019

    37thVaccination, Immunization & Antibiotics

    Vancouver, Canada
    November 12-13, 2019

    35th World Vaccines & Immunization Congress

    Brisbane, Australia

    RDT in Antibiotic Research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in